Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib

MLA

Meihua Jin, et al. “Inflammatory Biomarkers Predict Outcomes of Patients with Radioactive Iodine Refractory Thyroid Cancer Treated with Sorafenib.” Endocrine, Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e15fd347556f5c373ec7639cb3849772&authtype=sso&custid=ns315887.

APA

Meihua Jin, Mijin Kim, Min Ji Jeon, Eui Young Kim, Dong Yeob Shin, Bo Hyun Kim, Won Bae Kim, Young Kee Shong, Dong Jun Lim, & Won Gu Kim. (2023). Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib. Endocrine.

Chicago

Meihua Jin, Mijin Kim, Min Ji Jeon, Eui Young Kim, Dong Yeob Shin, Bo Hyun Kim, Won Bae Kim, Young Kee Shong, Dong Jun Lim, and Won Gu Kim. 2023. “Inflammatory Biomarkers Predict Outcomes of Patients with Radioactive Iodine Refractory Thyroid Cancer Treated with Sorafenib.” Endocrine, March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e15fd347556f5c373ec7639cb3849772&authtype=sso&custid=ns315887.